Vandetanib-induced phototoxicity in human keratinocytes NCTC-2544

Toxicology in Vitro

Volumn 28, Issue 5, 2014, Pages 803-811

  Salvador, Alessia ^a   Vedaldi, Daniela ^a   Brun, Paola ^a   Dall'Acqua, Stefano ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Apoptosis; DNA photodamage; Photolysis; Photoproducts; Phototoxicity; Vandetanib

Indexed keywords

ARYL RADICAL; FREE RADICAL; UNCLASSIFIED DRUG; VANDETANIB; ANTINEOPLASTIC AGENT; BOVINE SERUM ALBUMIN; N-(4-BROMO-2-FLUOROPHENYL)-6-METHOXY-7-((1-METHYLPIPERIDIN-4-YL)METHOXY)QUINAZOLIN-4-AMINE; PIPERIDINE DERIVATIVE; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; LIPID PEROXIDATION; LYSOSOME; MITOCHONDRION; OXIDATION; PHOTOTOXICITY; PROTEIN MODIFICATION; PROTEIN OXIDATION; ULTRAVIOLET A RADIATION; 3T3 CELL LINE; ANIMAL; CELL CYCLE; CELL LINE; CELL SURVIVAL; DERMATITIS, PHOTOTOXIC; DRUG EFFECTS; METABOLISM; MOUSE; OXIDATION REDUCTION REACTION; TOXICITY; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

3T3 CELLS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DERMATITIS, PHOTOTOXIC; DNA DAMAGE; HUMANS; LYSOSOMES; MICE; MITOCHONDRIA; OXIDATION-REDUCTION; PIPERIDINES; PROTEIN KINASE INHIBITORS; QUINAZOLINES; SERUM ALBUMIN, BOVINE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; ULTRAVIOLET RAYS;

EID: 84898832821     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.03.007     Document Type: Article

References (36)

1. Awtar K. Rapid flow cytofluorimetric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 1975, 66:188-193.
2. Balasubramanian D., Zigler J.S. The reaction of singlet oxygen with proteins, with special reference to crystallins. Photochem. Photobiol. 1990, 52:761-768.
3. Barraja P., Caracausi L., Diana P., Carbone A., Montalbano A., Cirrincione G., Brun P., Castagliuolo I., Dall'Acqua F., Vedaldi D., Salvador A. Synthesis of pyrrolo[3,2-h]quinolinones with good photochemotherapeutic activity and no DNA damage. Bioorg. Med. Chem. 2010, 18:4830-4843.
4. Broniscer A., Baker S.D., Wetmore C., Pai Panandiker A.S., Huang J., Davidoff A.M., Onar-Thomas A., Panetta J.C., Chin T.K., Merchant T.E., Baker J.N., Kaste S.C., Gajjar A., Stewart C.F. Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma. Clin. Cancer Res. 2013, 19:3050-3058.
5. Campbell M.J., Seib C.D., Gosnell J. Vandetanib and the management of advanced medullary thyroid cancer. Curr. Opin. Oncol. 2013, 25:39-43.
6. Chang C., Chang J.W.C., Hui C., Yang C. Severe photosensitivity reaction to vandetanib. J. Clin. Oncol. 2009, 27:e114-e115.
7. Ciulla T.A., Van Camp J.R., Rosenfeld E., Kochevar I.E. Photosensitization of single-strand breaks in pBR322 DNA by rose bengal. Photochem. Photobiol. 1989, 49:293-298.
8. Dall'Acqua S., Vedaldi D., Salvador A. Isolation and structure elucidation of the main UV-A photoproducts of vandetanib. J. Pharm. Biomed. Anal. 2013, 84:196-200.
9. Deleo V.A. Photocontact dermatitis. Dermatol. Ther. 2004, 17:279-288.
10. Diana P., Stagno A., Barraja P., Carbone A., Parrino B., Dall'Acqua F., Vedaldi D., Salvador A., Brun P., Castagliuolo I., Issinger O.G., Cirrincione G. Synthesis of triazenoazaindoles: a new class of triazenes with antitumor activity. ChemMedChem 2011, 6:1291-1299.
11. Elisei R., Cosci B., Romei C., Bottici V., Renzini G., Molinaro E., Agate L., Vivaldi A., Faviana P., Basolo F., Miccoli P., Berti P., Pacini F., Pinchiera A. Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J. Clin. Endocrinol. Metab. 2008, 93:682-687.
12. Fasani E., Profumo A., Albini A. Structure and medium-dependent photodecomposition of fluoroquinolone antibiotics. Photochem. Photobiol. 1998, 68:666-674.
13. Fava P., Quaglino P., Fierro M.T., Novelli M., Bernengo M.G. A rare vandetanib-induced photo-allergic drug eruption. Dermatol. Ther. 2010, 23:553-555.
14. Ferguson J. Photosensitivity due to drugs. Photoderm. Photoimmunol. Photomed. 2002, 18:262-269.
15. Kaewsuya P., Danielson N.D., Ekhterae D. Fluorescent determination of cardiolipin using 10-N-nonyl acridine orange. Anl. Bioanal. Chem. 2007, 387:2775-2782.
16. Kale J., Liu Q., Leber B., Andrews D.W. Shedding light on apoptosis at subcellular membranes. Cell 2012, 151:1179-1184.
17. Kochevar I.E., Garcia C., Gaecintov N.E. Photoaddition to DNA by nonintercalated chlorpromazine molecules. Photochem. Photobiol. 1998, 68:692-697.
18. Kong H.H., Fine H.A., Stern J.B., Chanco Turner M.L. Cutaneous pigmentation after photosensitivity induced by vandetanib therapy. Arch. Dermatol. 2009, 148:923-925.
19. Leboulleux S., Bastholt L., Krause T., de la Fouchardiere C., Tennvall J., Awada A., Gómez J.M., Bonichon F., Leenhardt L., Soufflet C., Licour M., Schumberger M.J. Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial. Lancet Oncol. 2012, 13:897-905.
20. Levine L.R., Garland D., Oliver C.N., Amici A., Climent A., Lenz A.G., Ahn B.G., Shaltier S., Stadman E.R. Determination of carbonyl content in oxidatively modified proteins. Meth. Enzymol. 1990, 186:464-480.
21. Mah L.-J., El-Osta A., Karagiannis T.C. ΓH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 2010, 24:679-686.
22. Marguery M.C., Chouini-Lalanne N., Ader J.C., Paillous N. Comparison of the DNA damage photoinduced by fenofibrate and ketoprofen, two phototoxic drugs of parent structure. Photochem. Photobiol. 1998, 68:679-684.
23. Musa K.A.K., Eriksson L.A. Photodegradation mechanism of the common non-steroid anti-inflammatory drug diclofenac and its carbazole photoproduct. Phys. Chem. Chem. Phys. 2009, 11:4601-4610.
24. Oliver L., Vallette F.M. The role of caspases in cell death and differentiation. Drug Res. Updates 2005, 8:163-170.
25. Ouedraogo G., Morliere P., Bazin M., Santus R., Kratzer B., Miranda M.A., Castell J.V. Lysosomes are sites of fluoroquinolone photosensitization in human skin fibroblasts: a microspectrofluorometric approach. Photochem. Photobiol. 1999, 70:123-129.
26. Roberts J.E. Ocular phototoxicity. J. Photochem. Photobiol. B: biol. 2001, 64:136-143.
27. Salvador A., Brognara E., Vedaldi D., Castagliuolo I., Brun P., Zuccato C., Lampronti I., Gambari R. Induction of eryhtroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts. J. Photochem. Photobiol. B: Biol. 2013, 121:57-66.
28. 6(3) or rhodamine 123, is a reliable fluorescent probe to assess δΨ changes in intact cells: implications for studies on mitochondrial funcionality during apoptosis. FEBS Lett. 1997, 411:77-82.
29. Schlumberger M., Bastholt L., Dralle H., Jarzab B., Pacini F., Smit J.W.A. 2012 European thyroid association guidelines for metastatic medullary thyroid cancer. Eur. Thyroid J. 2012, 1:5-14.
30. Stein K.R., Scheinfield N.S. Drug-induced photoallergic and phototoxic reactions. Expert Opin. Drug Saf. 2007, 6:431-443.
31. Thornton K., Kim G., Maher V.E., Chattopadhyay S., Tang S., Moon Y.J., Song P., Marathe A., Balakrishnan S., Zhu H., Garnett C., Liu Q., Booth B., Gehrke B., Dorsam R., Verbois L., Ghosh D., Wilson W., Duan J., Sarker H., Miksinski S.P., Ibrahim A., Justice R., Murgo A., Pazdur R. Vandetanib for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease: U.S. Food and Drug Administration drug approval summary. Clin. Cancer Res. 2012, 18:3722-3730.
32. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J. Immunol. Methods 1995, 184:39-51.
33. Viola G., Salvador A., Cecconet L., Basso G., Vedaldi D., Dall'Acqua F., Aloisi G.G., Amelia M., Barbafina B., Latterini L., Elisei F. Photophysical properties and photobiological behavior of amiodiaquine, primaquine and chloroquine. Photochem. Photobiol. 2007, 83:1415-1427.
34. Viola G., Grobelny P., Linardi M.A., Salvador A., Basso G., Mielcarek J., Dall'Acqua S., Vedaldi D., Dall'Acqua F. The phototoxicity of fluvastatin, an HMG-CoA reductase inhibitor, is mediated by the formation of a benzocarbazole-like photoproduct. Toxicol. Sci. 2010, 118:236-250.
35. Wender P.A., Jeon R. Bromoacetiphenone-based photonucleases: photoinduced cleavage of DNA by 4'-bromoacetophenone-pyrrolecarboxamide conjugates. Org. Lett. 1999, 1:2117-2120.
36. Zhao M., Eaton J.W., Brunk U.T. Protection against oxidant-mediated lysosomal rupture: a new anti-apoptotic activity?. FEBS Lett. 2000, 485:104-108.